Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced t ...

The therapy showed a ‘favourable’ safety profile both as a single agent and in combination with standard-of-care treatment.

Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced positive topline results from two ...

A new study published in the journal of BMC Endocrine Disorders showed that a high-quality carbohydrate diet with increased ...

U.S. News released its list of best diets for 2025: the low-FODMAP diet landed on top for irritable bowel syndrome and the ...

Moderate coffee consumption has been associated with improved cardiovascular health by lowering the risk of heart disease, ...

The following is a summary of “Association between the triglyceride-glucose index and liver fibrosis in adults with ...

Children's Hospital Colorado (Children's Colorado) has reached a historic milestone for its Liver Transplant Program, performing a record-breaking number of transplants in 2024. With 22 liver ...

Among the general US population, simple and affordable non-invasive liver fibrosis scoring systems may be able to identify individuals at risk for HF.

Arcturus Therapeutics initiates patient dosing in phase 2 multiple ascending dose studies for CF and OTC deficiency: San Diego Wednesday, January 8, 2025, 13:00 Hrs [IST] Arcturus ...

Patients with indeterminate chronic hepatitis B (CHB) phase are at risk of progressing to advanced liver disease and hepatocellular carcinoma (HCC), according to study results published in the Journal ...

Imphal, Prof. G. Sunil Kumar Sharma, inaugurated two advanced medical devices—a Fibroscan and a Portable Echo Ultrasound machine—at the Department of Medicine, RIMS, Imphal on Tuesday. The event was ...